**Page:** 15

| Operating income      | $ 2,610              | $ 2,328              | $ 9,995             | $ 9,447             |
A reconciliation of the Company's segment operating income to the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 is as follows (in millions):

|                                  | Three Months Ended   | Three Months Ended   | Nine Months Ended   | Nine Months Ended   |
|----------------------------------|----------------------|----------------------|---------------------|---------------------|
|                                  | June 29, 2024        | July 1, 2023         | June 29, 2024       | July 1, 2023        |
| Segment operating income         | $ 35,095             | $ 32,090             | $ 122,889           | $ 114,983           |
| Research and development expense | (8,006)              | (7,442)              | (23,605)            | (22,608)            |
| Other corporate expenses, net    | (1,737)              | (1,650)              | (5,659)             | (5,043)             |
| Total operating income           | $ 25,352             | $ 22,998             | $ 93,625            | $ 87,332            |